Brief: Supernus Reports Final Audited Fourth Quarter And Full Year 2021 Financial Results
13/04/2022 21:26
April 13 (Reuters) - Supernus Pharmaceuticals Inc SUPN.O :
* SUPERNUS REPORTS FINAL AUDITED FOURTH QUARTER AND FULL
YEAR 2021
FINANCIAL RESULTS
* SUPERNUS PHARMACEUTICALS INC - REITERATES FULL YEAR 2022
FINANCIAL GUIDANCE PROVIDED ON FEBRUARY 28, 2022 AND REITERATED
ON APRIL 4, 2022
Source text for Eikon: ID:nGNX6qn6Sc
Further company coverage: SUPN.O
Recent news on Supernus Pharmaceuticals
See all newsHuron Consulting poised to hit fresh record ahead of S&P SmallCap addition
Brief: S&P Dow Jones Indices Msg Rangers And Huron Consulting Group Set To Join S&P Smallcap 600
Brief: Supernus Pharmaceuticals Says FDA Grants Seven Years Orphan-Drug Exclusivity For Onapgo
Supernus Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE -Micron Technology, Ares Management, Boeing